Gel for Rapid Induction of Cancer Stem Cells
Rapid Production of Cancer Stem Cells Driving Tumor Recurrence to Accelerate Cancer Research.
Overview
The average cancer recurrence rate is approximately 20%. For aggressive cancers, the recurrence rate within five years can be as high as 70%. Cancer stem cells, known for their resistance to radiation and drug therapies, are considered a key cause of recurrence. Recently, drug discovery research targeting cancer stem cells has attracted significant attention. However, the extremely low abundance of these cells within tumor tissues presents a major challenge for research. Several methods have been proposed to induce cancer stem cells from cancer cells. However, all require high culture costs and long induction times, making them impractical for clinical application.
The present invention relates to a method of inducing cancer stem cells within 24 hours by culturing cancer cells on a double-network hydrogel (DN gel) without the use of drugs or genetic manipulation. Cancer stem cells induced by this method show increased expression of stem cell marker genes and exhibit tumor-forming ability even when injected in small numbers into mice.
By enabling simple and rapid production of cancer stem cells, this method is expected to accelerate the development of cancer therapies. These therapies aim to achieve fundamental cures by preventing recurrence and metastasis.
Cancer Stem Cells Induced by DN Gel
Product Application
□Scaffold material for inducing cancer stem cell
・ Development of novel therapeutics targeting cancer stem cells
・ Personalized medicine (prediction of individual patients’ cancer recurrence mechanisms)
Related Works
[1] Suzuka, J. et al., Nat. Biomed. Eng. 5, 914–925 (2021).
https://www.nature.com/articles/s41551-021-00692-2
[2] "Development of rapid induction of cancer stem cells by hydrogel" announced at JST New Technology Briefing on January 18, 2022
https://www.shingi.jst.go.jp/list/list_2021/2021_shika.html
IP Data
IP No. ： JP7115749, 11834671(US)
Inventor ： TANAKA Shinya, YASUDA Kazunori, GONG Jian Ping, TSUDA Masumi, KUROKAWA Takayuki
keyword ： cancer stem cell, reprogramming, anticancer agent